CIBA, Rembrandt Settle Contact Lens Patent Suit
Rembrandt Vision Technologies LP has dropped post-trial claims against eye care company CIBA Vision Corp., two months after the Novartis AG unit was ordered to pay Rembrandt $47.1 million for infringing...To view the full article, register now.
Already a subscriber? Click here to view full article